Please ensure Javascript is enabled for purposes of website accessibility

Walgreen Does It Again

By Lawrence A. Rothman, CFA – Updated Nov 14, 2016 at 11:47PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Walgreen is on the rise again.

Walgreen (NYSE:WAG) same-store sales (SSS) rose 5.1% in June. SSS are a key measure for retailers. Total sales can grow by merely opening new stores, but SSS measures growth at existing locations. Broken down, front-end sales increased 6.8%, and pharmacy sales grew 4.2%. This is important news since front-end sales typically have higher margins than pharmaceuticals. Basically, front-end sales are everything but prescriptions, and include items such as health and beauty products.

Walgreen continues to post strong year-over-year comparisons. Last June, Walgreen's SSS rose 9%, with pharmacy sales up 11.6%. Having one fewer Thursday and one more Saturday during the month compared to a year ago, management estimated that pharmacy SSS would have been 1.7% higher. While the 2.3% SSS increase for Rite Aid (NYSE:RAD) last quarter was good, this was compared to a very weak negative 0.3% from a year earlier.

Walgreen operates in a competitive industry. Competitors include other drugstore chains like CVS (NYSE:CVS), mail-order prescription providers like Medco Health Solutions (NYSE:MHS) and Express Scripts (NASDAQ:ESRX), and mass merchants like Wal-Mart (NYSE:WMT). However, Walgreen manages to distinguish itself by expanding into prime locations and making investments in technology and customer service. Front-end sales have continued to grow by staying ahead of the curve, entering new businesses such as digital photo services.

The company continues to impress, posting positive same-store sales results month after month. At a P/E of 21, I don't find the stock rich, given the solid performance that the company delivers.

For more on Walgreen, check out:

Wal-Mart is a Motley Fool Inside Value recommendation. To learn more about why value investing outperforms over time, sign up today for your free 30-day trial.

Fool contributor Larry Rothman is happy to receive feedback, and promises to read it when not being wrestled by his three children. Feel free to email him. He doesn't have any positions in the companies mentioned.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$32.83 (-1.47%) $0.49
Walmart Stock Quote
Walmart
WMT
$130.06 (-2.50%) $-3.33
Express Scripts Holding Company Stock Quote
Express Scripts Holding Company
ESRX
CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$98.35 (-1.48%) $-1.48
Rite Aid Corporation Stock Quote
Rite Aid Corporation
RAD
$7.01 (-0.99%) $0.07
Medco Health Solutions, Inc. Stock Quote
Medco Health Solutions, Inc.
MHS.DL

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.